- Patent Title: Antibody specific to spike protein of SARS-CoV-2 and uses thereof
-
Application No.: US18403419Application Date: 2024-01-03
-
Publication No.: US12157763B2Publication Date: 2024-12-03
- Inventor: Kuo-I Lin , Che Ma , Chi-Huey Wong , Szu-Wen Wang , Yi-Hsuan Chang , Xiaorui Chen , Han-Yi Huang
- Applicant: ACADEMIA SINICA
- Applicant Address: TW Taipei
- Assignee: ACADEMIA SINICA
- Current Assignee: ACADEMIA SINICA
- Current Assignee Address: TW Taipei
- Agency: Prosyla Group PC
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/42 ; A61K39/00
Abstract:
The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically binds to a spike protein of SARS-CoV-2. The present disclosure also relates to a pharmaceutical composition, a method for treating and/or preventing diseases and/or disorders caused by a coronavirus in a subject in need thereof, and a method for detecting a coronavirus in a sample.
Public/Granted literature
- US20240228591A1 ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF Public/Granted day:2024-07-11
Information query
